top of page
12 (3).png

Stem Cells and PRP Injections

Stem Cells and PRP Injections

Dr. Petty has decades of experience utilizing platelet-rich plasma (PRP) and regenerative stem cell therapies in the treatment of orthopedic injuries. He has performed thousands of these procedures for athletes at the highest level, including professional players from the Tennessee Titans, and routinely incorporates these therapies into the care of active individuals and non-athletes alike.

 

PRP and stem cell therapies are used selectively and thoughtfully, with treatment recommendations tailored to each patient’s condition, goals, and overall treatment plan. While these therapies can offer meaningful benefits, the primary limitation to their use is typically cost, as they are often not covered by insurance.

 

PRP has been safely used in orthopedic and surgical medicine since the 1990s. In 1999, Dr. Petty was the first physician at the Cleveland Clinic to design and implement a controlled study evaluating the effectiveness of PRP following total knee arthroplasty, specifically assessing its impact on reducing postoperative blood loss and knee stiffness. Although PRP is often perceived as a newer treatment, it has a long and well-established history and continues to gain recognition as research and clinical experience expand

Internal Bracing and Accelerated Recovery

Dr. Petty uses PRP and Mesenchymal Stem Cells derived from the patient’s bone marrow (BMAC) in the office setting and in the operating room to support healing of a wide range of musculoskeletal conditions, including:

​

  • Tendon and soft tissue injuries

  • Labral injuries in the shoulder and hip

  • Meniscal injuries of the knee

  • Ligament injuries of the hip, knee, elbow and shoulder

  • Muscle injuries

  • Degenerative joint conditions such as arthritis of the hip, knee, and shoulder

 

In many clinical scenarios, PRP has demonstrated outcomes comparable to stem cell therapies while offering a significantly lower cost, making it an effective and accessible regenerative option for many patients.

13 (4).png
bottom of page